Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 41

1.

Clinical testing patterns and cost implications of variation in the evaluation of CKD among US physicians.

Charles RF, Powe NR, Jaar BG, Troll MU, Parekh RS, Boulware LE.

Am J Kidney Dis. 2009 Aug;54(2):227-37. doi: 10.1053/j.ajkd.2008.12.044. Epub 2009 Apr 15.

2.

In the clinic. Chronic kidney disease.

Drawz P, Rahman M.

Ann Intern Med. 2009 Feb 3;150(3):ITC2-1-15; quiz ITC2-16. Review. No abstract available.

PMID:
19189903
3.

Phosphorus binders and survival on hemodialysis.

Isakova T, Gutiérrez OM, Chang Y, Shah A, Tamez H, Smith K, Thadhani R, Wolf M.

J Am Soc Nephrol. 2009 Feb;20(2):388-96. doi: 10.1681/ASN.2008060609. Epub 2008 Dec 17.

4.

Association of low-energy femoral fractures with prolonged bisphosphonate use: a case control study.

Lenart BA, Neviaser AS, Lyman S, Chang CC, Edobor-Osula F, Steele B, van der Meulen MC, Lorich DG, Lane JM.

Osteoporos Int. 2009 Aug;20(8):1353-62. doi: 10.1007/s00198-008-0805-x. Epub 2008 Dec 9.

5.

Awareness and knowledge of clinical practice guidelines for CKD among internal medicine residents: a national online survey.

Agrawal V, Ghosh AK, Barnes MA, McCullough PA.

Am J Kidney Dis. 2008 Dec;52(6):1061-9. doi: 10.1053/j.ajkd.2008.06.022. Epub 2008 Oct 30.

PMID:
18976845
6.

Recent developments in the management of postmenopausal osteoporosis with bisphosphonates: enhanced efficacy by enhanced compliance.

Boonen S, Vanderschueren D, Venken K, Milisen K, Delforge M, Haentjens P.

J Intern Med. 2008 Oct;264(4):315-32. doi: 10.1111/j.1365-2796.2008.02010.x. Review.

7.

Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis.

Gutiérrez OM, Mannstadt M, Isakova T, Rauh-Hain JA, Tamez H, Shah A, Smith K, Lee H, Thadhani R, Jüppner H, Wolf M.

N Engl J Med. 2008 Aug 7;359(6):584-92. doi: 10.1056/NEJMoa0706130.

8.

Chronic kidney disease and bone fracture: a growing concern.

Nickolas TL, Leonard MB, Shane E.

Kidney Int. 2008 Sep;74(6):721-31. doi: 10.1038/ki.2008.264. Epub 2008 Jun 18. Review.

9.

Chronic kidney disease, atherosclerosis, and cognitive and physical function in the geriatric group of the National Health and Nutrition Survey 1999-2002.

Lin CY, Lin LY, Kuo HK, Lin JW.

Atherosclerosis. 2009 Jan;202(1):312-9. doi: 10.1016/j.atherosclerosis.2008.04.020. Epub 2008 Apr 24.

PMID:
18533156
10.

Severely suppressed bone turnover and atypical skeletal fragility.

Visekruna M, Wilson D, McKiernan FE.

J Clin Endocrinol Metab. 2008 Aug;93(8):2948-52. doi: 10.1210/jc.2007-2803. Epub 2008 Jun 3.

PMID:
18522980
11.

Association of oral calcitriol with improved survival in nondialyzed CKD.

Shoben AB, Rudser KD, de Boer IH, Young B, Kestenbaum B.

J Am Soc Nephrol. 2008 Aug;19(8):1613-9. doi: 10.1681/ASN.2007111164. Epub 2008 May 7.

12.

An epidemic of chronic kidney disease: fact or fiction?

Glassock RJ, Winearls C.

Nephrol Dial Transplant. 2008 Apr;23(4):1117-21. doi: 10.1093/ndt/gfn086. Review. No abstract available.

PMID:
18359870
13.

Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate.

Lenart BA, Lorich DG, Lane JM.

N Engl J Med. 2008 Mar 20;358(12):1304-6. doi: 10.1056/NEJMc0707493. No abstract available.

14.

Association of activated vitamin D treatment and mortality in chronic kidney disease.

Kovesdy CP, Ahmadzadeh S, Anderson JE, Kalantar-Zadeh K.

Arch Intern Med. 2008 Feb 25;168(4):397-403. doi: 10.1001/archinternmed.2007.110.

PMID:
18299495
15.

Prevalence of chronic kidney disease in the United States.

Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS.

JAMA. 2007 Nov 7;298(17):2038-47.

PMID:
17986697
16.

Vitamin D levels and early mortality among incident hemodialysis patients.

Wolf M, Shah A, Gutierrez O, Ankers E, Monroy M, Tamez H, Steele D, Chang Y, Camargo CA Jr, Tonelli M, Thadhani R.

Kidney Int. 2007 Oct;72(8):1004-13. Epub 2007 Aug 8.

17.

Vitamin D deficiency.

Holick MF.

N Engl J Med. 2007 Jul 19;357(3):266-81. Review. No abstract available.

PMID:
17634462
18.

Secondary hyperparathyroidism due to hypovitaminosis D affects bone mineral density response to alendronate in elderly women with osteoporosis: a randomized controlled trial.

Barone A, Giusti A, Pioli G, Girasole G, Razzano M, Pizzonia M, Palummeri E, Bianchi G.

J Am Geriatr Soc. 2007 May;55(5):752-7.

PMID:
17493196
20.

Metabolic bone disease in chronic kidney disease.

Martin KJ, González EA.

J Am Soc Nephrol. 2007 Mar;18(3):875-85. Epub 2007 Jan 24. Review.

Supplemental Content

Support Center